|
Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)
RECRUITINGN/ASponsored by Pamukkale University
Actively Recruiting
PhaseN/A
SponsorPamukkale University
Started2026-04-01
Est. completion2026-08-30
Eligibility
Age40 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07473232
Summary
The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared
Eligibility
Age: 40 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:
1. Diagnosis of knee osteoarthritis according to ACR criteria at least 6 months ago.
2. Being between grade 1-2 according to the Kellgren-Lawrence radiological classification.
3. Not having had PRP injection in the last year.
4. Knee pain ≥ 5 according to the visual pain scale.
Exclusion Criteria:
1. Those with significant neurological or cardiovascular disorders.
2. Those with active thrombovascular disease.
3. Those with joint or skin infections.
4. Those who have recently had an infectious disease.
5. Those infected with Hepatitis B, C, and HIV.
6. Those who have received intra-articular knee injections (hyaluronic acid, PRP, corticosteroids, and others) within the last year.
7. Those who use oral corticosteroids.
8. Those who have used NSAIDs within the last week.
9. Those who have used anti-platelet or anti-aggregant drugs within the last week.
10. Those with coagulation disorders.
11. Those with hemoglobin \<10 g/dl and platelet count \<100,000
12. Those with cancer.
13. Pregnant or breastfeeding women, drug addicts.
14. Those scheduled for knee surgery or arthroscopy, or those who have undergone knee surgery or arthroscopy.
15. Those with diseases causing secondary osteoarthritis:
1. post-traumatic,
2. congenital or developmental diseases
1. Local diseases (leg length discrepancy, varus, valgus deformities, hypermobility syndromes, scoliosis)
2. Generalized diseases (Bone dysplasias, Metabolic disorders (hemochromatosis, ochronosis, Gaucher disease, hemoglobinopathy, Ehlers-Danlos disease))
3. Calcium storage diseases (calcium pyrophosphate storage disease, etc.)
4. Other bone and joint diseases (avascular necrosis, rheumatoid arthritis, gouty arthritis, septic arthritis, Paget's disease, osteoporosis, osteochondritis)
5. Other diseases
1. Endocrine diseases (Diabetes mellitus, acromegaly, hypothyroidism, hyperthyroidism)
2. Neuropathic arthropathy (Charcot joint)
3. Other (Frost, Kashin-Beck disease, Caisson disease) -Conditions4
ArthritisConditioned SerumKnee Arthritis, OsteoarthritisPlatelet Rich Plasma Injection
Interventions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorPamukkale University
Started2026-04-01
Est. completion2026-08-30
Eligibility
Age40 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07473232